Sandu Pharmaceuticals Ltd

Sandu Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sandu Pharmaceuticals Ltd

₹ 44.1 0.50%
24 Oct - close price
sandu.in BSE: 524703
About

Incorporated in 1985, Sandu Pharmaceuticals Ltd manufactures and trades Ayurvedic proprietary medicines.

Key Points

Product Portfolio:[1]
Company manufactures over 100 types of products, including oils, syrups, granules, powder, and avlehas, which are marketed under the Sandu brand viz, Sandu Ashoka Compound, Sandu Abhayarishta, Sandu Arvindasav, Sandu Balant Kadha No. 1, Sandu Debix Tablet, Sandu Bhunimbadi Kadha, Sandu Chandanasav Syrup, Sandu Chandraprabha, Sandu Chyavanprash Special, Sandu Dadimavaleha, etc.

Website BSE
  • Market Cap ₹ 42.6 Cr.
  • Current Price ₹ 44.1
  • High / Low ₹ 62.8 / 43.1
  • Stock P/E 27.5
  • Book Value ₹ 43.5
  • Dividend Yield 1.81 %
  • ROCE 5.47 %
  • ROE 3.75 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 1.01 times its book value
  • Company has been maintaining a healthy dividend payout of 34.3%

Cons

  • Company has a low return on equity of 3.80% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.53%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
11.42 16.23 16.76 17.09 15.26 17.66 16.61 17.43 15.60 17.05 17.70 18.37 14.07
10.85 15.91 15.90 16.27 14.77 17.31 15.79 16.92 14.99 16.64 16.79 17.37 13.62
Operating Profit 0.57 0.32 0.86 0.82 0.49 0.35 0.82 0.51 0.61 0.41 0.91 1.00 0.45
OPM % 4.99% 1.97% 5.13% 4.80% 3.21% 1.98% 4.94% 2.93% 3.91% 2.40% 5.14% 5.44% 3.20%
0.03 0.09 0.17 0.03 0.04 0.00 0.09 0.03 0.31 0.04 0.03 0.02 0.07
Interest 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.02 0.03 0.03 0.03
Depreciation 0.13 0.13 0.13 0.13 0.13 0.12 0.13 0.14 0.19 0.16 0.17 0.19 0.15
Profit before tax 0.45 0.26 0.88 0.70 0.38 0.21 0.77 0.38 0.72 0.27 0.74 0.80 0.34
Tax % 40.00% 34.62% 31.82% 30.00% 26.32% 47.62% 27.27% 44.74% 16.67% 40.74% 32.43% 30.00% 2.94%
0.27 0.17 0.60 0.48 0.27 0.11 0.55 0.21 0.59 0.17 0.50 0.56 0.33
EPS in Rs 0.31 0.19 0.62 0.50 0.28 0.11 0.57 0.22 0.61 0.18 0.52 0.58 0.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
65.50 65.35 67.28 67.19
62.62 62.87 64.98 64.43
Operating Profit 2.88 2.48 2.30 2.76
OPM % 4.40% 3.79% 3.42% 4.11%
0.08 0.33 0.42 0.17
Interest 0.11 0.08 0.06 0.10
Depreciation 0.53 0.52 0.58 0.67
Profit before tax 2.32 2.21 2.08 2.16
Tax % 31.47% 31.22% 29.33% 28.24%
1.59 1.52 1.46 1.55
EPS in Rs 1.80 1.57 1.51 1.60
Dividend Payout % 41.56% 0.00% 52.93% 49.86%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 1%
TTM: 0%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -1%
TTM: 6%
Stock Price CAGR
10 Years: 0%
5 Years: 8%
3 Years: -12%
1 Year: -24%
Return on Equity
10 Years: %
5 Years: %
3 Years: 4%
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8.81 9.66 9.66 9.66
Reserves 27.66 29.58 30.93 32.36
0.00 0.00 0.00 0.00
12.81 14.93 11.82 13.71
Total Liabilities 49.28 54.17 52.41 55.73
16.00 16.62 17.88 18.15
CWIP 0.48 0.42 0.00 0.00
Investments 9.11 9.65 10.42 11.22
23.69 27.48 24.11 26.36
Total Assets 49.28 54.17 52.41 55.73

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.95 0.22 0.76 0.95
-5.47 0.54 -1.31 -0.19
0.93 0.58 -0.72 -0.46
Net Cash Flow -3.59 1.34 -1.27 0.30

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 22.23 26.75 26.42 25.86
Inventory Days 115.06 167.70 137.28 160.90
Days Payable 69.63 98.30 47.07 51.05
Cash Conversion Cycle 67.67 96.15 116.63 135.70
Working Capital Days 42.41 52.33 56.75 62.80
ROCE % 6.05% 5.36% 5.47%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
50.43% 52.42% 52.42% 42.91% 42.91% 42.91% 42.91% 42.91% 42.91% 42.91% 42.91% 42.91%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
49.55% 47.59% 47.58% 57.10% 57.10% 57.09% 57.09% 57.09% 57.09% 57.09% 57.08% 57.09%
No. of Shareholders 10,26410,14110,12110,10310,02110,00110,01210,24610,33310,28710,22610,284

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings